In a recent study conducted by Jiang et al. (2018) on human breast cancer cells (MDA-MB-231) treated with C-PC, an important factor associated with cell death was shown to be linked with reduced cyclin D1 expression49. Here, CCND1 is linked to breast carcinoma.